{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:20:19Z","timestamp":1782951619995,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00296-020-04654-w","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T07:05:38Z","timestamp":1595315138000},"page":"605-610","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The effect of a nurse-led prednisolone tapering regimen in polymyalgia rheumatica: a retrospective cohort study"],"prefix":"10.1007","volume":"41","author":[{"given":"Christoffer","family":"M\u00f8rk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette Y.","family":"Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel G.","family":"Callsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2474-3389","authenticated-orcid":false,"given":"Kresten K.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"issue":"9","key":"4654_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.7326\/0003-4819-146-9-200705010-00005","volume":"146","author":"C Salvarani","year":"2007","unstructured":"Salvarani C, Macchioni P, Manzini C, Paolazzi G, Trotta A, Manganelli P, Cimmino M, Gerli R, Catanoso MG, Boiardi L, Cantini F, Klersy C, Hunder GG (2007) Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. Ann Intern Med 146(9):631\u2013639","journal-title":"Ann Intern Med"},{"issue":"7","key":"4654_CR2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.7326\/0003-4819-141-7-200410050-00005","volume":"141","author":"R Caporali","year":"2004","unstructured":"Caporali R, Cimmino MA, Ferraccioli G, Gerli R, Klersy C, Salvarani C, Montecucco C, Systemic Vasculitis Study Group of the Italian Society for R (2004) Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 141(7):493\u2013500","journal-title":"Ann Intern Med"},{"issue":"4","key":"4654_CR3","first-page":"624","volume":"23","author":"G Ferraccioli","year":"1996","unstructured":"Ferraccioli G, Salaffi F, De Vita S, Casatta L, Bartoli E (1996) Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study. J Rheumatol 23(4):624\u2013628","journal-title":"J Rheumatol"},{"issue":"4","key":"4654_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1136\/ard.55.4.218","volume":"55","author":"MJ van der Veen","year":"1996","unstructured":"van der Veen MJ, Dinant HJ, van Booma-Frankfort C, van Albada-Kuipers GA, Bijlsma JW (1996) Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? Ann Rheum Dis 55(4):218\u2013223","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"4654_CR5","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/art.1780401022","volume":"40","author":"SE Gabriel","year":"1997","unstructured":"Gabriel SE, Sunku J, Salvarani C, O'Fallon WM, Hunder GG (1997) Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum 40(10):1873\u20131878","journal-title":"Arthritis Rheum"},{"issue":"8","key":"4654_CR6","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1136\/ard.48.8.658","volume":"48","author":"V Kyle","year":"1989","unstructured":"Kyle V, Hazleman BL (1989) Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months. Ann Rheum Dis 48(8):658\u2013661","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"4654_CR7","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","volume":"74","author":"C Dejaco","year":"2015","unstructured":"Dejaco C, Singh YP, Perel P, Hutchings A, Camellino D, Mackie S, Abril A, Bachta A, Balint P, Barraclough K, Bianconi L, Buttgereit F, Carsons S, Ching D, Cid M, Cimmino M, Diamantopoulos A, Docken W, Duftner C, Fashanu B, Gilbert K, Hildreth P, Hollywood J, Jayne D, Lima M, Maharaj A, Mallen C, Martinez-Taboada V, Maz M, Merry S, Miller J, Mori S, Neill L, Nordborg E, Nott J, Padbury H, Pease C, Salvarani C, Schirmer M, Schmidt W, Spiera R, Tronnier D, Wagner A, Whitlock M, Matteson EL, Dasgupta B, European League Against R, American College of R (2015) 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis 74(10):1799\u20131807. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207492","journal-title":"Ann Rheum Dis"},{"issue":"4 Suppl 78","key":"4654_CR8","first-page":"S86","volume":"31","author":"F Muratore","year":"2013","unstructured":"Muratore F, Pipitone N, Hunder GG, Salvarani C (2013) Discontinuation of therapies in polymyalgia rheumatica and giant cell arteritis. Clin Exp Rheumatol 31(4 Suppl 78):S86\u201392","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"4654_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377\u2013381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"issue":"2","key":"4654_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/rheumatology\/37.2.189","volume":"37","author":"B Dasgupta","year":"1998","unstructured":"Dasgupta B, Dolan AL, Panayi GS, Fernandes L (1998) An initially double-blind controlled 96 week trial of depot methylprednisolone against oral prednisolone in the treatment of polymyalgia rheumatica. Br J Rheumatol 37(2):189\u2013195","journal-title":"Br J Rheumatol"},{"key":"4654_CR11","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.2147\/tcrm.S167452","volume":"15","author":"E Pelechas","year":"2019","unstructured":"Pelechas E, Voulgari PV, Drosos AA (2019) Clinical evaluation of the safety, efficacy and tolerability of sarilumab in the treatment of moderate to severe rheumatoid arthritis. Ther Clin Risk Manag 15:1073\u20131079. https:\/\/doi.org\/10.2147\/tcrm.S167452","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"4654_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0002-9343(85)90309-2","volume":"79","author":"WT Ayoub","year":"1985","unstructured":"Ayoub WT, Franklin CM, Torretti D (1985) Polymyalgia rheumatic. Duration of therapy and long-term outcome. Am J Med 79(3):309\u2013315. https:\/\/doi.org\/10.1016\/0002-9343(85)90309-2","journal-title":"Am J Med"},{"issue":"6","key":"4654_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/archinte.159.6.577","volume":"159","author":"CM Weyand","year":"1999","unstructured":"Weyand CM, Fulbright JW, Evans JM, Hunder GG, Goronzy JJ (1999) Corticosteroid requirements in polymyalgia rheumatica. Arch Intern Med 159(6):577\u2013584","journal-title":"Arch Intern Med"},{"issue":"1","key":"4654_CR14","first-page":"99","volume":"25","author":"S Bahlas","year":"1998","unstructured":"Bahlas S, Ramos-Remus C, Davis P (1998) Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis. J Rheumatol 25(1):99\u2013104","journal-title":"J Rheumatol"},{"issue":"5","key":"4654_CR15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1080\/030097401753180327","volume":"30","author":"G Myklebust","year":"2001","unstructured":"Myklebust G, Gran JT (2001) Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis. A prospective two-year study in 273 patients. Scand J Rheumatol 30(5):260\u2013267","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"4654_CR16","first-page":"1945","volume":"26","author":"J Narvaez","year":"1999","unstructured":"Narvaez J, Nolla-Sole JM, Clavaguera MT, Valverde-Garcia J, Roig-Escofet D (1999) Longterm therapy in polymyalgia rheumatica: effect of coexistent temporal arteritis. J Rheumatol 26(9):1945\u20131952","journal-title":"J Rheumatol"},{"issue":"12","key":"4654_CR17","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1136\/ard.52.12.847","volume":"52","author":"V Kyle","year":"1993","unstructured":"Kyle V, Hazleman BL (1993) The clinical and laboratory course of polymyalgia rheumatica\/giant cell arteritis after the first two months of treatment. Ann Rheum Dis 52(12):847\u2013850","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"4654_CR18","first-page":"1340","volume":"17","author":"I Lundberg","year":"1990","unstructured":"Lundberg I, Hedfors E (1990) Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis. J Rheumatol 17(10):1340\u20131345","journal-title":"J Rheumatol"},{"issue":"4","key":"4654_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.rdc.2019.07.001","volume":"45","author":"JS Smolen","year":"2019","unstructured":"Smolen JS (2019) Treat to target in rheumatology: a historical account on occasion of the 10th anniversary. Rheum Dis Clin N Am 45(4):477\u2013485. https:\/\/doi.org\/10.1016\/j.rdc.2019.07.001","journal-title":"Rheum Dis Clin N Am"},{"issue":"9430","key":"4654_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/s0140-6736(04)16676-2","volume":"364","author":"C Grigor","year":"2004","unstructured":"Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, Kincaid W, Porter D (2004) Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364(9430):263\u2013269. https:\/\/doi.org\/10.1016\/s0140-6736(04)16676-2","journal-title":"Lancet"},{"issue":"4","key":"4654_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/rheumatology\/kew395","volume":"56","author":"A Abhishek","year":"2017","unstructured":"Abhishek A, Jenkins W, La-Crette J, Fernandes G, Doherty M (2017) Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study. Rheumatology (Oxford) 56(4):529\u2013533. https:\/\/doi.org\/10.1093\/rheumatology\/kew395","journal-title":"Rheumatology (Oxford)"},{"issue":"10156","key":"4654_CR22","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","volume":"392","author":"M Doherty","year":"2018","unstructured":"Doherty M, Jenkins W, Richardson H, Sarmanova A, Abhishek A, Ashton D, Barclay C, Doherty S, Duley L, Hatton R, Rees F, Stevenson M, Zhang W (2018) Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial. Lancet (London, England) 392(10156):1403\u20131412. https:\/\/doi.org\/10.1016\/S0140-6736(18)32158-5","journal-title":"Lancet (London, England)"},{"key":"4654_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa011","author":"SW Borresen","year":"2020","unstructured":"Borresen SW, Thorgrimsen TB, Jensen B, Hilsted L, Bartels EM, Feldt-Rasmussen U, Locht H (2020) Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach. Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/keaa011","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"4654_CR24","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","volume":"39","author":"TP van Staa","year":"2000","unstructured":"van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 39(12):1383\u20131389. https:\/\/doi.org\/10.1093\/rheumatology\/39.12.1383","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"4654_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/archinte.1994.00420010131015","volume":"154","author":"JH Gurwitz","year":"1994","unstructured":"Gurwitz JH, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J (1994) Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch Intern Med 154(1):97\u2013101","journal-title":"Arch Intern Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04654-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04654-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04654-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T23:30:07Z","timestamp":1626823807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04654-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["4654"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04654-w","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,21]]},"assertion":[{"value":"3 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Danish Data Protection Agency (case number 1-16-02-295-18, approval date 30.10.2018) and the Danish Patient Safety Authority (case number 3-3013-2689\/1, approval date 22.06.2018).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}